The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Warrant Exercise, CLN Repayment and TVR

7 Oct 2020 11:57

RNS Number : 3978B
Pathfinder Minerals Plc
07 October 2020
 

7 October 2020

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Warrant Exercise, CLN Repayment and TVR

 

Pathfinder announces that it has received notice of the exercise of warrants to subscribe for a total of 1,166,666 new ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares"). These warrants were issued as part of the Company's Convertible Loan Note fundraising announced on 3 April 2020 ("April 2020 CLN") and the exercise price of these warrants was 0.6p per warrant.

As documented in the April 2020 CLN agreement, the funds received by the Company in relation to the exercise of these warrants will be netted off against the principal repayments due to the applicable April 2020 CLN holders on 1 December 2020. As such, the outstanding principal amount has further reduced from £109,000 to £102,000.

The interest due on the April 2020 CLN has also been reduced as a result of the exercise of warrants from £6,752 to £6,568 at expiry on 1 December 2020. No other terms of the April 2020 CLN have been affected.

Application for Admission to Trading on AIM and Total Voting Rights

Application will be made for the 1,166,666 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 14 October 2020.

Upon Admission, the Company's issued share capital will consist of 372,390,497 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 372,390,497. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Dennis Edmonds, Chairman of Pathfinder, commented:

 

"The exercise of these warrants, at what is the current market price, coupled with the positions recently taken by the Chief Executive Officer, Non-Executive Director and a major shareholder, is testament to the confidence that exists within the Pathfinder Board of achieving a resolution to the licence dispute over Mining Concession 4623C in Mozambique. We look forward to updating the market in the near future."

 

 

Enquiries:

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44 +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

Novum Securities Limited (Broker)

Colin Rowbury / Jon Belliss

Tel. +44 (0)20 7399 9400

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPGAAUUPUGUM
Date   Source Headline
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants
6th May 20223:10 pmRNSIssue of Equity and TVR
12th Apr 20227:00 amRNSCompany Strategy Update
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
4th Oct 20214:30 pmRNSGrant of Share Options
14th Sep 20217:00 amRNSHalf-year Results
19th Jul 20213:13 pmRNSChange of Registered Office
30th Jun 202111:47 amRNSResult of Annual General Meeting
29th Jun 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
24th Jun 202111:00 amRNSGrant of Share Options
9th Jun 202110:38 amRNSGrant of Share Options
7th Jun 20217:02 amRNSChange of Adviser
7th Jun 20217:01 amRNSNotice of AGM
7th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSDirector Appointment
21st May 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
12th May 20215:40 pmRNSHolding(s) in Company
12th May 202112:33 pmRNSHolding(s) in Company
4th May 20213:40 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
1st Apr 20215:58 pmRNSGrant of Share Options
1st Apr 20215:57 pmRNSHolding(s) in Company
29th Mar 20212:07 pmRNSResult of General Meeting - Replacement
29th Mar 202112:29 pmRNSResult of General Meeting
17th Mar 20217:00 amRNSDirectorate Change
10th Mar 20217:00 amRNSNotice of General Meeting
1st Mar 202110:59 amRNSChange of Auditor
19th Feb 20213:34 pmRNSStrategy Update, Placing, CLN Amendment & TVR
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
20th Jan 202112:22 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
6th Jan 20212:01 pmRNSPrice Monitoring Extension
29th Dec 20204:32 pmRNSDirector/PDMR Shareholding
16th Dec 20203:32 pmRNSBilateral Investment Treaty Claim – Legal Opinion
11th Dec 20207:00 amRNSUpdate Re Mining Licence
30th Nov 20207:00 amRNSRecovery of Costs Awards
18th Nov 20205:15 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSCLN Conversion and Final Settlement
5th Nov 202011:32 amRNSCLN Maturity Date
4th Nov 20207:00 amRNSIssue of Warrants
2nd Nov 20207:00 amRNSCompany Strategy Update
30th Oct 20207:00 amRNSHalf-year Report
29th Oct 20207:00 amRNSChange of Admission Date
22nd Oct 20207:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.